+$64.1M
Net Activity
Institutions Holding
80
Popularity Rank
#4957
Avg Weight
0.14%
Total Value
$221.6M
80 institutions currently hold CLYM, with 50 net buyers and 32 net sellers this quarter.
Institutional Moves (Q1 2026)
Majority Increased
Based on recent trading activity
Net Selling Institutions
32
Net Buying Institutions
50
Top 5 by Value
+$145.6M
Total Buy Value
$53.6M
Total Sell Value
50
Net Buyers
32
Net Sellers
1
Filings (90d)
$407K
Total Est. Value
31K shares
Planned Shares
| Filer | Filing Date | Est. Value |
|---|---|---|
| Brennan Aoife | 2026-06-30 | $407K |
Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。
No Schedule 13D/13G filings for this ticker
1
Filings (14d)
Climb Bio, Inc. announced that director Andrew Levin resigned on June 29, 2026, and Breanna O'Reilly, Ph.D., was elected to the board the same day. Dr. O'Reilly received a stock option grant for 70,284 shares at $13.36 per share, vesting over three years, plus a $40,000 annual cash retainer and future equity grants under the standard non-employee director compensation policy.
View Full Filing (SEC EDGAR)The most-added stocks by 13F institutions this quarter
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter